

Diabetic retinopathy is a diabetes-related eye condition that can affect your vision. The disease develops gradually so understanding its stages, progression, early intervention and preventive measures is crucial for maintaining eye health and avoiding severe vision loss.
Diabetic retinopathy progresses through several stages:
Maculopathy refers to diseases or damage affecting the macula, the central part of the retina responsible for sharp, detailed vision. When changes occur in this area, they can lead to vision problems such as blurriness, distortion, or, in severe cases, vision loss. To classify these changes, a grading system is used:
The progression rate of diabetic retinopathy varies among individuals. Factors influencing this include blood sugar control, blood pressure, cholesterol levels, and the duration of diabetes. Regular eye examinations and early interventions are vital to protect vision.
Traditionally, NHS treatments for diabetic retinopathy, such as eye injections and laser therapy, are only offered once the disease has significantly progressed. Unfortunately, waiting until later stages means the eye has already suffered damage.
Unlike invasive NHS treatments, Noctura 400 offers a proactive approach to managing diabetic eye disease. It is a non-invasive therapy that prevents the disease from progressing, reducing the need for painful injections or laser treatment. With no waiting lists and the ability to use it at home, Noctura 400 empowers individuals to take control of their eye health early, ensuring they maintain their ability to work, drive, and enjoy life with clear vision.
If you have diabetes, regular eye screenings and early intervention are essential. Don’t wait for symptoms to worsen before taking action — preventative treatment can make all the difference. Noctura 400 can be purchased privately online, and provides an affordable and accessible option to protect your vision before severe complications arise.
If you have Diabetic Retinopathy or Diabetic Macular Oedema and you live in England, Wales, Scotland or Northern Ireland, check with your doctor to see if you are eligible.


